Share

Related Links

Related Stories

  • Proceedings of the 2nd Annual London Genetics Pharmacogenetics conference 2010 Pharmacogenetics: Why, How and When?
    The importance of pharmacogenetics and stratified medicine as part of the drug development processes is now widely acknowledge, offering the opportunity to address many of the challenges facing the biopharmaceutical industry today and supporting an era where cost-effectiveness and value-based pricing rule. Moving on from the inaugural London Genetics Pharmacogenetic conference in 2009, at which the role of pharmacogenetics in drug discovery and development was debated, the 2nd London Genetics conference, entitled ‘Pharmacogenetics – Why, How and When?’ focused on how and when to apply stratified approaches from drug discovery through to cost-effectiveness evaluation and reimbursement.
  • Biowales March 1 and 2 Showcases Country’s Biosciences Sector
    BioWales 2011 returns to the Vale Hotel near Cardiff on March 1st and 2nd with a conference, exhibition and biopartnering event reflecting the significance of the life sciences sector in Wales. Bringing together industry professionals, academics and clinicians, BioWales sets a platform to promote breakthroughs in new technologies, gain insights into the latest trends and developments and make valuable connections.
  • Transatlantic research partnership aims for longer, healthier lives
    Research efforts to help the world's ageing population live longer, healthier lives have been given a major boost with the announcement of six new transatlantic research projects that aim to understanding the biology of the ageing process.
  • Oxford University launches new vaccinology programme
    Vaccine developers with insight into the latest advances will be drivers of innovation within the vaccine industry, yet there is a lack of available training courses in the field.
  • Drug Discovery Oxford 2012
    The Drug Discovery Oxford 2012 – “Drug discovery: a job too complex for academia or industry alone?” conference is only a month away.

Top 5 Stories

News

GSM Association and the University of Manchester to establish an m-Health Innovation Centre

11 November 2009

The GSM Association today announced that it has signed a Memorandum of Understanding with the University of Manchester to establish an m-Health Innovation Centre in Manchester, which will act as a UK focus for m-Health activity.

The goal of the GSM Association (GMSA)'s m-Health initiative is to encourage mobile applications and services in healthcare that will promote healthier lifestyles and early intervention.

The Manchester m-Health Innovation Centre will conduct multidisciplinary research and bring together researchers, healthcare organizations and industrial partners to conceive, develop and evaluate mobile health innovations. Their focus will be on citizen-led health and wellbeing, using mobile technology to allow people a more active role in determining their own health and to provide a more personalized interface for public services.

The centre in Manchester will provide a forum for collaboration and sharing ideas, providing in-depth analysis of the market for m-Health, signposting key opportunities, conducting pilot trials, organizing community events, providing m-Health education and training, and offering online resources and one-to-one services to support the emerging m-Health community.

‘A combination of mobile and healthcare can deliver tremendous benefits, such as cost savings for healthcare providers, as well as convenience and improved quality of life for patients,’ said Michael O'Hara, Chief Marketing Officer at the GSMA. ‘We are delighted to be collaborating with the University of Manchester, a leading centre for Health Informatics research, innovation and education, and whose deep expertise and focus makes them an ideal partner for our m-Health collaboration.’

‘We very much value the opportunity to work with the GSMA to translate our innovative ideas into practice,’ said Professor Dame Nancy Rothwell FRS, Deputy President and Deputy Vice-Chancellor, University of Manchester. ‘Sustainable health and wellbeing represent a major challenge for society worldwide, and the transformational potential of mobile technology in promoting innovative citizen-led health initiatives provides exciting opportunities.’

The Manchester m-Health Innovation Centre is working on a variety of health projects that can use mobile technology, including 'assisted living applications' prompting patients (e.g. people with psychotic disorders) to record the medication they are taking, their symptoms and their mood in real time via their mobile phone. Using mobile technology for prompting and feedback is particularly relevant for young people, who are the largest group of sufferers of psychotic disorders in the UK.

Other projects are planned, such as Virtual Health Kiosks, linked seamlessly and securely to clinical and/or personal health record systems via mobile technology, for monitoring blood pressure, pulse, temperature and glucose levels at home or in the office.

 

This article is featured in:
Companies and People  •  Novel Technologies

 

Comment on this article

You must be registered and logged in to leave a comment about this article.